Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-046917
Filing Date
2019-08-20
Accepted
2019-08-20 20:38:47
Documents
1
Period of Report
2019-08-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4155
  Complete submission text file 0001209191-19-046917.txt   5624
Mailing Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Issuer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MILLENDO THERAPEUTICS, INC. 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address
Zeidan Ryan (Reporting) CIK: 0001785724 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35890 | Film No.: 191041122